Inc. magazine reports that Thiel Capital has expressed interest in a new clinical trial involving transfusion of blood from young people into older people — something Thiel has previously ...

Somewhere in a white-walled room in Silicon Valley, Peter Thiel might be getting a blood transfusion from a younger person. Or he wants to be. Or he already has. On Monday, Inc. published a story ...

This explains Thiel’s interest in Ambrosia, a California-based company conducting a clinical trial that gives participants over the age of 35 (who have to shell out $8,000 to take part in the ...

The revelation that 48-year old venture capitalist Peter Thiel is interested in younger people's blood to help extend life spawned a whole array of vampire jokes on social media such as: BREAKING ...

Thiel, the Silicon Valley billionaire now on Donald Trump’s transition team, garnered attention (and accusations of vampirism) for being “very interested” in the potential of young blood to ...

Venture capitalist Peter Thiel has said he’s interested in the possibility of young blood transfusions, and one company called Ambrosia is currently conducting a human trial of such transfusions.

DealBook’s host, Andrew Ross Sorkin, waited to ask Thiel if he injects himself with young blood until the last question. “On the record. I am not a vampire,” Thiel said.

U.S. & World; Peter Thiel thinks harvesting, injecting blood of the young is key to eternal life. Published: ; Aug. 01, 2016, 7:23 p.m.